Literature DB >> 2534844

Activation versus tolerance: a decision made by T helper cells.

S Guerder1, P Matzinger.   

Abstract

Mesh：

Substances：

Year:  1989        PMID： 2534844     DOI： 10.1101/sqb.1989.054.01.093

Source DB:  PubMed          Journal:  Cold Spring Harb Symp Quant Biol        ISSN： 0091-7451


× No keyword cloud information.
  8 in total

Review 1.  Does the signal for the activation of T cells originate from the antigen-presenting cell or the effector T-helper?

Authors:  Melvin Cohn
Journal:  Cell Immunol       Date:  2006-09-11       Impact factor: 4.868

2.  Long-lasting CD8 T cell memory in the absence of CD4 T cells or B cells.

Authors:  F Di Rosa; P Matzinger
Journal:  J Exp Med       Date:  1996-05-01       Impact factor: 14.307

3.  Thymus epithelium induces tissue-specific tolerance.

Authors:  A Bonomo; P Matzinger
Journal:  J Exp Med       Date:  1993-04-01       Impact factor: 14.307

4.  Generation of T cells with lytic specificity for atypical antigens. III. Priming F1 animals with antigen-bearing cells also having reactivity for host alloantigens allows for potent lytic T cell responses.

Authors:  J D Davies; D H Wilson; D B Wilson
Journal:  J Exp Med       Date:  1991-04-01       Impact factor: 14.307

5.  A fail-safe mechanism for maintaining self-tolerance.

Authors:  S Guerder; P Matzinger
Journal:  J Exp Med       Date:  1992-08-01       Impact factor: 14.307

6.  Induction of long-term H-Y-specific tolerance in female mice given male lymphoid cells while transiently depleted of CD4+ or CD8+ T cells.

Authors:  F P VanderVegt; L L Johnson
Journal:  J Exp Med       Date:  1993-06-01       Impact factor: 14.307

7.  B cells directly tolerize CD8(+) T cells.

Authors:  S R Bennett; F R Carbone; T Toy; J F Miller; W R Heath
Journal:  J Exp Med       Date:  1998-12-07       Impact factor: 14.307

8.  A quantitative analysis of antigen-presenting cell function: activated B cells stimulate naive CD4 T cells but are inferior to dendritic cells in providing costimulation.

Authors:  D J Cassell; R H Schwartz
Journal:  J Exp Med       Date:  1994-11-01       Impact factor: 14.307
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.